ImpriMed
imprimedicine.com
Healthcare
ImpriMed uses live-cell testing and AI to predict drug responses for veterinary oncology and human blood cancers, aiding pharma drug development. It operates from Palo Alto and Seoul.
Founded
2017
Total Funding
$10M+
Total Rounds
4
First Raise
Apr 15, 2019
Latest Raise
Sep 21, 2026
Get notified when ImpriMed and companies like it raise
New funding rounds in your inbox every week · No noise, all Signal.
Organization Chart
Founders and leadership hierarchy for this company.
Contact details require Sales or Enterprise
Open Roles
Loading open roles...
All Funding Rounds
Showing 1 of 4 rounds
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 9/21/2026 | |||
3 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Company Performance Metrics
Premium Feature
Upgrade to Premium to view Capital Momentum Score and performance metrics
ImpriMed · Never miss the next round
Who's raising next?
New funding rounds in your inbox every week · Free